PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26125566-4	2015	The aim of this study was to investigate the role of NGAL as an early and accurate indicator of DGF and Tacrolimus (Tac) toxicity and as a mediator of tissue regeneration in KT from ECD.	Tacrolimus	104-114	lipocalin 2	Homo sapiens	53-57	
31242630-2	2019	The urinary neutrophil gelatinase-associated lipocalin (NGAL) level has been linked to tacrolimus-induced AKI in patients starting tacrolimus treatment the morning after liver transplantation.	Tacrolimus	87-97	lipocalin 2	Homo sapiens	12-54	
31242630-2	2019	The urinary neutrophil gelatinase-associated lipocalin (NGAL) level has been linked to tacrolimus-induced AKI in patients starting tacrolimus treatment the morning after liver transplantation.	Tacrolimus	87-97	lipocalin 2	Homo sapiens	56-60	
31242630-2	2019	The urinary neutrophil gelatinase-associated lipocalin (NGAL) level has been linked to tacrolimus-induced AKI in patients starting tacrolimus treatment the morning after liver transplantation.	Tacrolimus	131-141	lipocalin 2	Homo sapiens	12-54	
31242630-2	2019	The urinary neutrophil gelatinase-associated lipocalin (NGAL) level has been linked to tacrolimus-induced AKI in patients starting tacrolimus treatment the morning after liver transplantation.	Tacrolimus	131-141	lipocalin 2	Homo sapiens	56-60	
30576367-0	2018	Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation.	Tacrolimus	138-148	lipocalin 2	Homo sapiens	22-64	
30794705-0	2019	Correction: Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation.	Tacrolimus	95-105	lipocalin 2	Homo sapiens	34-76	
30794705-0	2019	Correction: Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation.	Tacrolimus	150-160	lipocalin 2	Homo sapiens	34-76	
30576367-0	2018	Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation.	Tacrolimus	83-93	lipocalin 2	Homo sapiens	22-64	
26125566-4	2015	The aim of this study was to investigate the role of NGAL as an early and accurate indicator of DGF and Tacrolimus (Tac) toxicity and as a mediator of tissue regeneration in KT from ECD.	Tacrolimus	104-107	lipocalin 2	Homo sapiens	53-57	
25329716-0	2014	Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients.	Tacrolimus	75-85	lipocalin 2	Homo sapiens	8-50	
25329716-11	2014	In addition, the urinary levels of NGAL at postoperative day 1 (p = 0.0446) and day 7 (p = 0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively.	Tacrolimus	135-145	lipocalin 2	Homo sapiens	35-39	
25329716-12	2014	In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.	Tacrolimus	57-67	lipocalin 2	Homo sapiens	23-27	
25329716-12	2014	In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.	Tacrolimus	124-134	lipocalin 2	Homo sapiens	23-27